Genetic variation in CYP19A1 and occurrence of adverse events in exemestane treatment with early breast cancer patients in the Dutch TEAM trial

Author(s):
Houtsma, D.; Fontein, D.; Straaten, T. van der; Baak-Pablo, R.; Wessels, J.A.M.; Seynaeve, C.; Velde, C.J.H.V. de; Nortier, J.W.R.; Gelderblom, H.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-05-20
Language
English
Is part of
Journal of Clinical Oncology (2013), No. 15
hdl
1887/104667